8.32
price up icon2.46%   0.20
after-market 시간 외 거래: 8.34 0.02 +0.24%
loading
전일 마감가:
$8.12
열려 있는:
$8.29
하루 거래량:
92,685
Relative Volume:
0.67
시가총액:
$288.45M
수익:
$239.40M
순이익/손실:
$104.44M
주가수익비율:
2.8108
EPS:
2.96
순현금흐름:
$-18.50M
1주 성능:
+9.47%
1개월 성능:
-0.12%
6개월 성능:
-61.46%
1년 성능:
-47.34%
1일 변동 폭
Value
$8.29
$8.59
1주일 범위
Value
$7.62
$8.59
52주 변동 폭
Value
$7.10
$21.79

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Name
명칭
Entrada Therapeutics Inc
Name
전화
857-305-1825
Name
주소
ONE DESIGN CENTER PLACE, BOSTON
Name
직원
183
Name
트위터
Name
다음 수익 날짜
2024-08-12
Name
최신 SEC 제출 서류
Name
TRDA's Discussions on Twitter

TRDA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TRDA
Entrada Therapeutics Inc
8.32 288.45M 239.40M 104.44M -18.50M 2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-06 개시 ROTH MKM Buy
2024-01-05 개시 Oppenheimer Outperform
2023-04-03 개시 H.C. Wainwright Buy

Entrada Therapeutics Inc 주식(TRDA)의 최신 뉴스

pulisher
Jun 06, 2025

Mackenzie Financial Corp Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

How the (TRDA) price action is used to our Advantage - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 04, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock Position Trimmed by Nuveen Asset Management LLC - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Entrada Therapeutics expands board with new director By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics expands board with new director - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics (TRDA) Welcomes New Board Member | TRDA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics Appoints New Board Member - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

3,324 Shares in Entrada Therapeutics, Inc. (NASDAQ:TRDA) Bought by BNP Paribas Financial Markets - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Buys 2,517 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Buy Rating for Entrada Therapeutics: Strategic Positioning and Regulatory Advances in Exon-Skipping Therapeutics - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

Deutsche Bank AG Grows Stock Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 31, 2025
pulisher
May 29, 2025

Entrada Therapeutics to start DMD trial in Q3 2025 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Entrada Therapeutics (TRDA) Gains EU Approval for Advanced Clinical Study | TRDA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Entrada Therapeutics to start DMD trial in Q3 2025 - Investing.com

May 28, 2025
pulisher
May 28, 2025

Entrada Therapeutics Receives EU Authorization to Proceed with ELEVATE-45-201 Clinical Study for Duchenne Muscular Dystrophy, Set to Begin in Q3 2025 - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Breakthrough DMD Treatment Gets EU Green Light: Entrada's Novel Exon 45 Therapy Heads to Clinical Trials - Stock Titan

May 28, 2025
pulisher
May 23, 2025

HC Wainwright Brokers Boost Earnings Estimates for TRDA - Defense World

May 23, 2025
pulisher
May 22, 2025

Layoff Tracker: Boundless Laying Off 33% of Staff - BioSpace

May 22, 2025
pulisher
May 22, 2025

Q2 Earnings Forecast for TRDA Issued By HC Wainwright - Defense World

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Reiterates Buy Rating for Entrada Therapeutics (NASDAQ:TRDA) - Defense World

May 22, 2025
pulisher
May 21, 2025

Northern Trust Corp Has $5.50 Million Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 21, 2025
pulisher
May 20, 2025

Entrada Therapeutics (TRDA) Receives 'Buy' Rating Reiteration by HC Wainwright | TRDA Stock News - GuruFocus

May 20, 2025
pulisher
May 17, 2025

Tower Research Capital LLC TRC Cuts Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 17, 2025
pulisher
May 15, 2025

(TRDA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 15, 2025
pulisher
May 15, 2025

Roth Capital Issues Negative Outlook for TRDA Earnings - Defense World

May 15, 2025
pulisher
May 14, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 14, 2025
pulisher
May 12, 2025

Entrada Therapeutics price target lowered to $21 from $23 at Roth Capital - TipRanks

May 12, 2025
pulisher
May 12, 2025

Entrada Therapeutics (TRDA) Sees Price Target Adjustment Amid Cl - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Roth Capital Adjusts Price Target for Entrada Therapeutics (TRDA - GuruFocus

May 12, 2025
pulisher
May 11, 2025

Roth Capital Adjusts Price Target for Entrada Therapeutics (TRDA) | TRDA Stock News - GuruFocus

May 11, 2025
pulisher
May 11, 2025

Analysts Are Upgrading Entrada Therapeutics, Inc. (NASDAQ:TRDA) After Its Latest Results - Yahoo Finance

May 11, 2025
pulisher
May 08, 2025

Entrada Therapeutics: Strategic Advancements in DMD Pipeline Drive Buy Rating - TipRanks

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics reports Q1 EPS (42c), consensus (77c) - TipRanks

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics earnings beat by $0.31, revenue fell short of estimates - Investing.com

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics (TRDA) Reports Strong Q1 Revenue and Advances Duchenne Programs | TRDA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics Reports First Quarter 2025 Financial Results - The Manila Times

May 08, 2025
pulisher
May 08, 2025

First Trust Advisors LP Sells 7,800 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 08, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Acquires 1,731 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 08, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Buys 3,357 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 08, 2025
pulisher
May 06, 2025

Barclays PLC Has $887,000 Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 06, 2025
pulisher
May 06, 2025

Analysts Are Bullish on Top Healthcare Stocks: ImmunityBio (IBRX), Axsome Therapeutics (AXSM) - The Globe and Mail

May 06, 2025
pulisher
May 05, 2025

Form 8-KCurrent report - ADVFN

May 05, 2025
pulisher
May 05, 2025

Finance Watch: Unity Lays Off All Employees As It Evaluates Alternatives - insights.citeline.com

May 05, 2025
pulisher
May 05, 2025

Invesco Ltd. Takes Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 05, 2025
pulisher
May 05, 2025

Entrada Therapeutics (TRDA) Projected to Post Earnings on Tuesday - Defense World

May 05, 2025
pulisher
May 01, 2025

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for - MSN

May 01, 2025

Entrada Therapeutics Inc (TRDA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):